CytoDyn Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

394.89M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2024	-	-	-
May 31, 2023	-	-	-
May 31, 2022	266.00K	-	-
May 31, 2021	-	-	-
May 31, 2020	-	-	-
May 31, 2019	Pro	Pro	Pro
May 31, 2018	Pro	Pro	Pro
May 31, 2017	Pro	Pro	Pro
May 31, 2016	Pro	Pro	Pro
May 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo, Inc.	1.73B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Elite Pharmaceuticals	84.04M
Glass House Brands	215.62M
Northwest Biotherapeutics	1.47M
American Oncology Network	1.76B
Silence Therapeutics	27.70M

Revenue Rankings

CytoDyn News

20 days ago - CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab - GlobeNewsWire
27 days ago - CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer - GlobeNewsWire
7 weeks ago - A Penny Stock To Watch In Challenging Cancer Space - Benzinga
2 months ago - CytoDyn Releases ESMO Breast Cancer Meeting Poster - GlobeNewsWire
2 months ago - CytoDyn highlights potential of lead drug against solid tumors with new data - Seeking Alpha
2 months ago - CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors - GlobeNewsWire
2 months ago - CytoDyn appoints Robert Hoffman as CFO - Seeking Alpha
2 months ago - CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - Benzinga

More News